黑色素瘤治療市場 - 2025 年至 2030 年預測

Melanoma Treatment Market - Forecasts from 2025 to 2030

出版日期: 2025年07月04日 | 出版商:

Knowledge Sourcing Intelligence | 英文 142 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

黑色素瘤治療市場預計將從 2025 年的 75.1 億美元成長到 2030 年的 98.15 億美元，複合年成長率為 5.50%。

近年來，氣候變遷導致新增病例報告增加。這些變化導致全球黑色素瘤患者發病率上升，增加了對合適治療方法的需求。如果及早發現並治療，該疾病在很大程度上是可以治癒的。人均收入的提高、醫療設施的改善、健康意識的增強、醫療保險服務的普及以及醫學和生物醫學的進步也是推動市場擴張的因素。

從地區來看，北美佔據市場佔有率。美國皮膚癌的高發生率是市場成長的主要驅動力。從類型來看，皮膚黑色素瘤在世界各地廣泛存在，其原因是過度暴露於陽光紫外線和室內曬黑。從治療方法來看，標靶治療因其副作用低、療效高，逐漸贏得市場佔有率。

黑色素瘤治療市場成長要素：

擴大監管核准

對高效治療方法研發的日益重視以及由此帶來的投資成長，可能會對市場成長產生正面影響。治療建議取決於諸多因素，但監管部門核准數量的增加對市場成長的影響最大。主要公司專注於推出創新治療方案和藥物，這可能會在未來幾年推動市場成長。

黑色素瘤治療市場的領導企業包括默克公司、安進公司、Iovance Biotherapeutics公司、百時美施貴寶公司、羅氏公司、衛材株式會社、諾華公司、輝瑞公司、賽諾菲和阿斯特捷利康。

In recent years, there has been a rise in the number of new cases reported due to climatic changes. These changes are increasing the incidence of melanoma patients worldwide, raising the demand for proper methods of treatment. If detected and treated early, the disease is almost always curable. The rising per capita income, better health facilities, growing health awareness, the availability of health insurance services, and advancement in medical science and bio-medicines are additionally factoring in the expansion of the market.

Geographically, North America dominates the market share. The high prevalence of skin-related cancer in the United States is a major factor contributing to the market's growth. By type, cutaneous melanoma is widely spread globally and caused by too much exposure to ultraviolet rays from the sun and indoor tanning. Based on therapy, targeted therapy is gaining market share due to fewer side effects and high efficiency rates.

Melanoma Treatment Market Growth Factors:

Growing regulatory approvals

The high emphasis and consequently the elevated investment in the development of efficient treatment options are likely to have a positive impact on the growth of the market. Treatment recommendations depend on many factors, and the increasing number of regulatory approvals has had the highest impact on market growth. The emphasis of significant companies on introducing innovative treatment options and drugs will aid the market's growth in the coming years.

Some of the market leaders in the melanoma treatment market are Merck & Co. Inc., Amgen Inc., Iovance Biotherapeutics, Inc., Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd, Eisai Co., Ltd., Novartis AG, Pfizer Inc., Sanofi, and AstraZeneca.

Melanoma Treatment Companies:

Merck & Co. Inc.
Amgen Inc.
Iovance Biotherapeutics, Inc.
Bristol-Myers Squibb
F. Hoffmann-La Roche Ltd.

Melanoma Treatment Market Segmentation:

By Type

Cutaneous Melanoma
Ocular Melanoma
Mucosal Melanoma

By Therapy

Surgery
Immunotherapy
Targeted Therapy
Chemotherapy
Radiation Therapy

By Geography

North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Others
Asia Pacific
China
India
Japan
South Korea
Indoensia
Thailand
Others

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. MELANOMA TREATMENT MARKET BY TYPE

5.1. Introduction
5.2. Cutaneous Melanoma
5.3. Ocular Melanoma
5.4. Mucosal Melanoma

6. MELANOMA TREATMENT MARKET BY THERAPY

6.1. Introduction
6.2. Surgery
6.3. Immunotherapy
6.4. Targeted Therapy
6.5. Chemotherapy
6.6. Radiation Therapy

7. MELANOMA TREATMENT MARKET BY GEOGRAPHY

7.1. Introduction
7.2. North America
- 7.2.1. USA
- 7.2.2. Canada
- 7.2.3. Mexico
7.3. South America
- 7.3.1. Brazil
- 7.3.2. Argentina
- 7.3.3. Others
7.4. Europe
- 7.4.1. Germany
- 7.4.2. France
- 7.4.3. United Kingdom
- 7.4.4. Spain
- 7.4.5. Others
7.5. Middle East and Africa
- 7.5.1. Saudi Arabia
- 7.5.2. UAE
- 7.5.3. Others
7.6. Asia Pacific
- 7.6.1. China
- 7.6.2. India
- 7.6.3. Japan
- 7.6.4. South Korea
- 7.6.5. Indonesia
- 7.6.6. Thailand
- 7.6.7. Others